Comparing High Tone Power Therapy and TENS for Diabetic Nerve Pain
High Tone Power Therapy Versus Transcutanuoselectrical Nerve Stimulation on Polyneuropathic Pain in Diabetic Patients
This study is testing if High Tone Power Therapy can help relieve nerve pain in diabetic men better than TENS therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 50 Years to 60 Years |
| Sex | Male |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza) |
| Trial ID | NCT06822218 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of High Tone Power Therapy compared to Transcutaneous Electrical Nerve Stimulation (TENS) in alleviating polyneuropathic pain in diabetic patients. Sixty male patients aged 50-60 with diabetic polyneuropathy will be randomly assigned to receive either therapy three times a week for three months. The High Tone Power Therapy will utilize a frequency range of 4096 Hz to 31768 Hz, while TENS will use frequencies from 2 to 120 Hz. The goal is to identify a non-pharmacological treatment option that can improve patient symptoms and enhance their quality of life.
Who should consider this trial
Good fit: Ideal candidates are male patients aged 50-60 with a diagnosis of diabetic polyneuropathy who are independently ambulant.
Not a fit: Patients with psychiatric disorders, other neuromuscular disorders, or those with foot deformities and ulcers may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new non-invasive treatment option for managing diabetic polyneuropathic pain.
How similar studies have performed: Previous studies have shown promise in using electrical stimulation techniques for neuropathic pain, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient selection will be according to the following criteria: 1. Sixty male patients are diagnosed with diabetic polyneuropathy their ages will be ranged from 50-60 years old. 2. All patients are ambulant independently. 3. All patients are under full medical control 4. HbA1c is ranged from 6.5 : 7 %. 5. Patients has diabetes more than 10 years. Exclusion Criteria: * The participants will be excluded if they meet one of the following criteria: 1. Psychiatric disorders or seizures. 2. Visual and auditory impairment or tremors influencing balance. 3. Other neuromuscular disorders. 4. Foot deformities and ulcers. 5. Lower limb operations. 6. Feverish systemic infection 7. cardiac pacemaker.
Where this trial is running
Giza
- Om Elmasryeen Genral Hospital — Giza, Egypt (Recruiting)
Study contacts
- Study coordinator: zeinab Awadallah, master
- Email: zeezee.awad88@hotmail.com
- Phone: +201285819342
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.